Yitao Jia
Overview
Explore the profile of Yitao Jia including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
378
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xu Y, Qi J, Liu J, Jia Y
Tob Induc Dis
. 2024 Aug;
22.
PMID: 39206381
Introduction: Lung cancer is a significant cause of mortality, especially among smokers. Lung cancer and smoking are strongly associated, according to numerous studies. Methods: Publications related to smoking and lung...
2.
Wang F, Chen L, Liu L, Jia Y, Li W, Wang L, et al.
J Cancer Res Clin Oncol
. 2023 Jul;
149(13):12177-12189.
PMID: 37428248
Purpose: Due to the rarity of primary gastrointestinal lymphoma (PGIL), the prognostic factors and optimal management of PGIL have not been clearly defined. We aimed to establish prognostic models using...
3.
Yuan N, Li X, Wang M, Zhang Z, Qiao L, Gao Y, et al.
Gut Liver
. 2022 Mar;
16(4):575-588.
PMID: 35318288
Background/aims: This study aimed to explore the effect of gut microbiota-regulated Kupffer cells (KCs) on colorectal cancer (CRC) liver metastasis. Methods: A series of and researches were showed to demonstrate...
4.
Xin G, Cao X, Zhao W, Lv P, Qiu G, Li Y, et al.
Math Biosci Eng
. 2020 Dec;
17(6):8074-8083.
PMID: 33378933
ObjectThe current study was performed to construct a model with microRNA (miRNA/miR) expression profile and TNM staging system for prognosis predicting in patients with lung adenocarcinoma (LUAD). MethodsDifferentially expressed miRNAs...
5.
Kuai W, Xu X, Yan J, Zhao W, Li Y, Wang B, et al.
Biomed Res Int
. 2020 Jun;
2020:5294043.
PMID: 32509862
Background: Programmed cell death receptor 1 (PD-1) and T cell immunoglobulin mucin-3 (Tim-3) are considered as important immunosuppressive molecules and play an important role in tumor immune escape and cancer...
6.
Xu X, Lv J, Guo F, Li J, Jia Y, Jiang D, et al.
Front Microbiol
. 2020 May;
11:814.
PMID: 32425919
Colorectal cancer (CRC) appears to be rather refractory to checkpoint blockers except the patient with deficient in mismatch repair (dMMR). Therefore, new advances in the treatment of most mismatch repair...
7.
Jia X, Wang H, Li Z, Yan J, Guo Y, Zhao W, et al.
Mol Med Rep
. 2020 Apr;
21(4):1779-1788.
PMID: 32319604
Colorectal cancer (CRC) remains one of the most common cancer types worldwide. A few previous studies have examined whether HER4 may promote the progression of CRC. The present study examined...
8.
Lv J, Jia Y, Li J, Kuai W, Li Y, Guo F, et al.
Cell Death Dis
. 2019 May;
10(6):415.
PMID: 31138779
Therapeutic antibodies targeting PD-1 have made major breakthroughs in cancer treatment. However, the majority of colorectal cancer (CRC) cases are microsatellite stable (MSS) and do not respond to anti-PD-1-based immunotherapy....
9.
Zhang Y, Li Z, Zhao Z, Kuai W, Wei C, Lv J, et al.
Evid Based Complement Alternat Med
. 2019 Mar;
2019:3870812.
PMID: 30891076
Background: Fatigue is a common, distressing, and persistent symptom for patients with malignant tumor including colorectal cancer (CRC). Although studies of cancer-related fatigue (CRF) have sprung out in recent years,...
10.
Ma C, Guo Y, Zhang Y, Duo A, Jia Y, Liu C, et al.
Biochem Biophys Res Commun
. 2018 May;
501(3):654-660.
PMID: 29758199
Platelet-activating factor acetylhydrolase IB subunit beta (PAFAH1B2) plays important roles in inflammation and anaphylaxis. However, its primary function in pancreatic cancer remains unclear. In the current study, we report that...